z-logo
open-access-imgOpen Access
Is it oncologically and clinically safe to adopt a bladder sparing approach in complete responders following neoadjuvant chemotherapy alone without proceeding to a radical cystectomy?
Author(s) -
Ranjan Arianayagam,
Anand Sharma,
Nikhil Vasdev
Publication year - 2018
Publication title -
translational andrology and urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.721
H-Index - 27
eISSN - 2223-4691
pISSN - 2223-4683
DOI - 10.21037/tau.2018.08.18
Subject(s) - cystectomy , bladder cancer , chemotherapy , medicine , urology , neoadjuvant therapy , oncology , cancer , breast cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here